Introduction
The veterinary pharmaceutical industry is experiencing a significant transformation with the adoption of oral disintegrating films (ODFs) as an innovative drug delivery system. The global veterinary oral thin films market is projected to grow at a compound annual growth rate of 10.98% through 2031, driven by increasing pet ownership and the need for easier medication administration[1]. Unlike traditional tablets that require 80-90% of active substances to be broken down by the digestive system, veterinary ODFs deliver over 90% bioavailability through sublingual absorption, bypassing the digestive tract entirely[1].
Setting up an oral thin film making machine for veterinary applications requires careful consideration of equipment specifications, formulation requirements, and regulatory compliance. Aligned Machinery provides integrated pharmaceutical equipment solutions designed to meet the unique demands of veterinary ODF production, combining technical excellence with comprehensive support for manufacturers entering this rapidly expanding market.
Quick Answer
An oral thin film making machine for veterinary ODF production consists of five core components: a precision mixing system for homogeneous dispersion of active pharmaceutical ingredients (APIs) and excipients, a controlled coating system with knife-over-roll technology, a temperature-controlled drying unit, an automated cutting and slitting mechanism, and packaging equipment for individual dose units. The most widely adopted manufacturing method is solvent casting, which offers scalability from laboratory to commercial production while maintaining dose uniformity and film quality[2].
| Component | Function | Key Specification |
|---|---|---|
| Mixing System | Homogeneous API dispersion | Low-shear or high-shear mixer with thermostatic control |
| Coating System | Film formation | Knife-over-roll coater with precise pin gauge |
| Drying Unit | Solvent evaporation | Hot-air oven with designated temperature control |
| Cutting System | Dose unit creation | Automated slitting for 2×3 cm film dimensions |
| Packaging Equipment | Individual unit sealing | Child-resistant, tamper-proof pouches |
Core Components of an Oral Thin Film Making Machine
The oral thin film making machine comprises several integrated systems that work together to produce consistent, high-quality veterinary ODFs. Each component plays a critical role in ensuring product efficacy and regulatory compliance.
The mixing system forms the foundation of ODF production. This system precisely dispenses drugs, excipients, and FDA-approved class III solvents, followed by homogeneous dispersion in temperature-controlled mixers[2]. For veterinary applications, low-shear mixers are preferred when working with encapsulated drug actives to prevent removal of encapsulating material. Aligned Machinery’s mixing systems incorporate thermostatic control to maintain optimal viscosity throughout the process.
The coating and casting system applies the formulation onto a carefully selected liner using knife-over-roll coating technology. This system features precise pin gauges that control film thickness, typically maintaining dimensions under 100 µm for optimal oral cavity placement[2]. The coating process must ensure uniform distribution of the API across the entire film surface to guarantee dose accuracy in each unit.
Manufacturing Methods for Veterinary ODF Production
Solvent casting technology has emerged as the preferred method for veterinary ODF manufacturing due to its simplicity, cost-effectiveness, and scalability[3]. In this process, film-forming polymers such as sodium alginate, hydroxypropylmethyl cellulose (HPMC), or polyvinyl alcohol (PVA) are dissolved in suitable solvents along with the active pharmaceutical ingredient. A recent study demonstrated successful furosemide-loaded ODF production using sodium alginate as the film-forming agent, achieving 97.63% drug content uniformity and 33.5-second disintegration time[4].
Alternative manufacturing technologies include hot-melt extrusion (HME), which eliminates solvent use entirely by mixing APIs and excipients in a dry state before heating and extrusion[3]. While HME offers advantages for certain formulations, solvent casting remains the industry standard for veterinary applications due to its proven track record and regulatory acceptance. Aligned Machinery supports both methodologies, providing manufacturers with flexibility to choose the most appropriate technology for their specific veterinary drug formulations.
Critical Setup Considerations for Veterinary Applications
Veterinary ODF production presents unique challenges compared to human pharmaceutical manufacturing. Animals, particularly cats and small dogs, often resist oral tablet administration, leading to medication non-compliance during long-term treatment protocols[4]. The oral thin film making machine must accommodate formulations that address taste masking, rapid dissolution, and species-specific palatability requirements.
Film dimensions for veterinary applications typically range from 2×2 cm to 2×3 cm with maximum thickness of 100 µm to fit comfortably in the oral cavity[2]. The machine’s cutting system must deliver precise dimensional control to ensure consistent dosing across production batches. Quality control systems should monitor weight uniformity, with acceptable ranges typically within ±5% of target weight. For the furosemide veterinary ODF study, mean film weight was 51.75 ± 2.25 mg with excellent uniformity[4].
GMP Compliance and Validation Requirements
Regulatory compliance is paramount when setting up an oral thin film making machine for veterinary pharmaceutical production. The equipment must meet Good Manufacturing Practice (GMP) standards and support comprehensive validation protocols. Key validation parameters include temperature control accuracy in drying units, coating thickness consistency, and API content uniformity across production runs.
The machine should facilitate process analytical technology (PAT) integration for real-time monitoring of critical quality attributes. Documentation capabilities must support batch record generation, deviation tracking, and change control procedures. Aligned Machinery’s equipment comes with validation support packages that include installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ) protocols tailored to veterinary ODF production requirements.
Residual solvent testing is particularly critical for solvent casting methods. The equipment must enable complete solvent evaporation while maintaining API stability, with residual levels meeting regulatory thresholds to prevent toxicity concerns[2]. Temperature control systems should maintain designated ranges throughout the drying process, with automated monitoring and alarm systems for deviation detection.
FAQ
What is the typical production capacity of a veterinary ODF machine?
Production capacity varies by scale, ranging from laboratory units producing 100-500 films per hour to commercial-scale machines capable of 10,000+ films per hour. Mid-scale equipment typically processes 2,000-5,000 films hourly, suitable for contract manufacturing organizations and regional veterinary pharmaceutical producers.
How long does machine setup and validation take?
Complete setup including installation, validation, and operator training typically requires 4-8 weeks. This timeline includes equipment installation (1-2 weeks), IQ/OQ/PQ validation protocols (2-3 weeks), process optimization (1-2 weeks), and comprehensive operator training on formulation handling and quality control procedures.
What film-forming polymers work best for veterinary applications?
Sodium alginate, HPMC, and polyvinyl alcohol are the most commonly used film-forming polymers for veterinary ODFs. Sodium alginate offers excellent film-forming properties and biocompatibility, while HPMC provides superior mechanical strength. Polymer selection depends on the specific API, desired dissolution profile, and target animal species.
Can one machine handle multiple veterinary drug formulations?
Yes, modern oral thin film making machines support multi-product manufacturing with appropriate cleaning validation between batches. Equipment should include CIP (clean-in-place) capabilities and changeover protocols to prevent cross-contamination. Aligned Machinery designs systems with modular components that facilitate efficient product transitions while maintaining GMP compliance.
What are the key differences between human and veterinary ODF production?
Veterinary ODF production requires enhanced taste masking due to animals’ sensitivity to bitter compounds, species-specific palatability testing, and often smaller film dimensions for companion animals. Formulations must account for different metabolic pathways and may require flavoring agents like meat or fish extracts rather than fruit flavors used in human products.
Conclusion
Setting up an oral thin film making machine for veterinary ODF production represents a strategic investment in the rapidly growing animal health market. Success requires careful selection of equipment components, thorough understanding of manufacturing methodologies, and unwavering commitment to GMP compliance. The solvent casting approach offers the most proven pathway for manufacturers entering this space, with established validation protocols and regulatory acceptance.
Aligned Machinery brings decades of pharmaceutical equipment expertise to veterinary ODF production, offering turnkey solutions from initial setup through ongoing technical support. Our integrated approach covers equipment selection, installation, validation, and operator training, ensuring manufacturers can confidently enter the veterinary oral thin film market. With the global veterinary ODF market expanding at nearly 11% annually, now is the optimal time to establish production capabilities for this innovative drug delivery platform.
Contact Aligned Machinery today to discuss your veterinary ODF production requirements and discover how our comprehensive equipment solutions can accelerate your market entry while ensuring regulatory compliance and production excellence.
References
[1] Absolute Markets Insights. (2023). Introduction of Innovative Oral Thin Films With Various Infusions is Propelling the Veterinary Oral Thin Films Market. https://www.einpresswire.com/article/643886875/introduction-of-innovative-oral-thin-films-with-various-infusions-is-propelling-the-veterinary-oral-thin-films-market
[2] Pharmaceutics. (2023). Orodispersible Films: Current Innovations and Emerging Trends. https://pmc.ncbi.nlm.nih.gov/articles/PMC10747242/
[3] CD Formulation. (2023). Oral Thin Film Manufacturing Technologies. https://www.formulationbio.com/oral-thin-film/oral-thin-film-manufacturing-technologies.html
[4] BMC Veterinary Research. (2021). Pharmacokinetics and diuretic effect of furosemide after single intravenous, oral tablet, and newly developed oral disintegrating film administration in healthy dogs. https://pmc.ncbi.nlm.nih.gov/articles/PMC8420016/
Post time: Jun-22-2026